Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alterola Biotech Inc (OP: ABTI )

0.0050 +0.0010 (+25.00%)
Streaming Delayed Price Updated: 9:47 AM EST, Nov 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alterola Biotech Inc

Bright Green Announces Fourth Quarter 2022 Financial Update
From Bright Green Corporation
Via GlobeNewswire
Bright Green Announces Appointment of Seamus McAuley, Chief Operating Officer of Bright Green, as Chief Executive Officer
From Bright Green Corporation
Via GlobeNewswire
Bright Green Provides Update on Progress as It Prepares for Multiple Activities in 2023
From Bright Green Corporation
Via GlobeNewswire
ALTEROLA Biotech INC. acquires ABTI pharma ltd
Via AB Newswire
Bright Green Strengthens its Scientific Advisory Board with the Appointment of Five Additional Biotech and Pharmaceutical Leaders
Expansion of Bright Green’s Scientific Advisory Board supports its mission to be the premier federally-authorized provider of cannabis and derivative products 
From Bright Green Corporation
Via GlobeNewswire
Bright Green Announces Close of Transaction with Alterola Biotech
From Bright Green Corporation
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another breakdown of the biggest pre-market stock movers as we cover what's moving shares on Thursday morning! 
Via InvestorPlace
ALTEROLA BIOTECH INC. ACQUIRES ABTI PHARMA LTD
Alterola Biotech Inc. acquires ABTI Pharma Ltd as part of its strategic move into the cannabinoid medicines sector. Liverpool, UK, 22 July 2021, ZEXPRWIRE, Alterola Biotech Inc. (OTC: ABTI), today... 
Via Zexprwire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.